Category: Abbott Laboratories
Here's a look at some of the top legal news stories for medical device companies this week: Lawyer says Guidant didn't breach deal with J&J; Ex-Abbott stent liaison alleges retaliation for compliance complaint; Trial date set for Boston Scientific executive's accused killer; Analogic expects fines in BK Medical's Danish bribery beef; SEC dings Bruker in $2.4m China bribery case
A former Abbott Vascular medical liaison alleges that the company fired her after she flagged Abbott for off-label promotion of its Xience stent and pre-approval marketing of its bioresorbable vascular scaffold.
Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Medtech M&A explodes in 2014; Synergetics pays $14m for Sterimedix; Report: Lawyer says Guidant didn't breach deal with J&J
Guidant was within its rights to give due diligence materials to Abbott, even though it had an acquisition deal going with Johnson & Johnson, a former Guidant lawyer reportedly testifies.
Abbott Vascular reportedly lays off 100 workers at a plant in Temecula, Calif.
Abbott Vascular (NYSE:ABT) is laying off about 100 workers at a California plant it acquired when it bought a portion of Guidant Corp. in 2006.
Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Medtronic unveils post-merger management structure; Abbott buys into electrophysiology with $250m Topera acquisition; Zimmer reveals post-Biomet merger plans; Medtronic, Covidien merger expected to close in 2015; Covidien deals Stellarex balloon to Spectranetics for $30m
Abbott pays $250 million plus milestones for Topera Medical and its cardiac arrhythmia mapping technology and inks a deal to acquire Advanced Cardiac Therapeutics and its ablation catheter.